Source: CNBC
The American biotech company, Gilead Sciences, came to an agreement with the administration to donate an HIV transmission prevention drug, Truvada, for 200,000 Americans every year.
The agreement is expected to last through 2025, providing thousands of individuals with the drug, which usually costs upwards of $1,600 a month. The administration apparently agreed to cover the costs for getting those medications to people in need.
The donation, Trump tweeted, “Will help us achieve our goal of ending the HIV epidemic in America!”
Across the globe there are more than 36 million people living with HIV, and approximately 21 million of those individuals are using drug treatments to help suppress the infection, according to CNBC.
Read Full Story: CNBC